$NEO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEOGENOMICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NEOGENOMICS INC. Get notifications about new insider transactions in NEOGENOMICS INC for free.
Page: < prev 1 2 3 4 5 6 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 28 2018 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Option Exercise | A | 8.03 | 72,500 | 582,175 | 72,500 | |
Feb 28 2018 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | A | 8.03 | 288,500 | 2,316,655 | 288,500 | |
Feb 28 2018 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | Chief Financial Off ... | Option Exercise | A | 8.03 | 192,500 | 1,545,775 | 192,500 | |
Feb 28 2018 | NEO | NEOGENOMICS INC | ROSS STEVEN A | CIO | Option Exercise | A | 8.03 | 72,500 | 582,175 | 72,500 | |
Feb 28 2018 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | A | 8.03 | 636,000 | 5,107,080 | 636,000 | |
Feb 28 2018 | NEO | NEOGENOMICS INC | BRODIE STEVEN G. | Vice President of O ... | Option Exercise | A | 8.03 | 58,000 | 465,740 | 58,000 | |
Dec 14 2017 | NEO | NEOGENOMICS INC | JONES STEVEN C | Executive Vice Pres ... | Gift | G | 9.06 | 20,000 | 181,200 | 226,251 | 246.3 K to 226.3 K (-8.12 %) |
Oct 20 2017 | NEO | NEOGENOMICS INC | McKenzie Kathryn B | Principal Accountin ... | Option Exercise | A | 9.07 | 25,000 | 226,750 | 25,000 | |
Aug 25 2017 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Option Exercise | X | 3.45 | 15,000 | 51,750 | 0 | |
Aug 25 2017 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Option Exercise | X | 3.76 | 7,500 | 28,200 | 0 | |
Aug 25 2017 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Sell | D | 9.38 | 22,500 | 211,050 | 0 | 22.5 K to 0 (-100.00 %) |
Aug 25 2017 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Buy | M | 3.76 | 7,500 | 28,200 | 22,500 | 15 K to 22.5 K (+50.00 %) |
Aug 25 2017 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Buy | M | 3.45 | 15,000 | 51,750 | 15,000 | 0 to 15 K |
Jul 31 2017 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Buy | P | 9.19 | 20,000 | 183,800 | 38,782 | 18.8 K to 38.8 K (+106.48 %) |
Jul 06 2017 | NEO | NEOGENOMICS INC | BRODIE STEVEN G. | Vice President of O ... | Option Exercise | X | 3.45 | 6,666 | 22,998 | 13,334 | |
Jul 06 2017 | NEO | NEOGENOMICS INC | BRODIE STEVEN G. | Vice President of O ... | Buy | M | 3.45 | 6,666 | 22,998 | 32,619 | 26 K to 32.6 K (+25.68 %) |
Jun 28 2017 | NEO | NEOGENOMICS INC | JONES STEVEN C | Executive Vice Pres ... | Buy | J | 0.00 | 190,000 | 0 | 190,000 | 0 to 190 K |
Jun 28 2017 | NEO | NEOGENOMICS INC | JONES STEVEN C | Executive Vice Pres ... | Sell | J | 0.00 | 190,000 | 0 | 190,000 | 380 K to 190 K (-50.00 %) |
Jun 26 2017 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Sell | S | 8.49 | 10,723 | 91,038 | 0 | 10.7 K to 0 (-100.00 %) |
Jun 06 2017 | NEO | NEOGENOMICS INC | ROSS STEVEN A | CIO | Option Exercise | X | 4.78 | 33,333 | 159,332 | 33,667 | |
Jun 06 2017 | NEO | NEOGENOMICS INC | ROSS STEVEN A | CIO | Option Exercise | X | 3.93 | 37,500 | 147,375 | 0 | |
Jun 06 2017 | NEO | NEOGENOMICS INC | ROSS STEVEN A | CIO | Sell | S | 7.79 | 45,833 | 357,039 | 4,500 | 50.3 K to 4.5 K (-91.06 %) |
Jun 06 2017 | NEO | NEOGENOMICS INC | ROSS STEVEN A | CIO | Sell | S | 7.79 | 10,000 | 77,900 | 50,333 | 60.3 K to 50.3 K (-16.57 %) |
Jun 06 2017 | NEO | NEOGENOMICS INC | ROSS STEVEN A | CIO | Sell | S | 7.63 | 15,000 | 114,450 | 60,333 | 75.3 K to 60.3 K (-19.91 %) |
Jun 06 2017 | NEO | NEOGENOMICS INC | ROSS STEVEN A | CIO | Buy | M | 4.78 | 33,333 | 159,332 | 75,333 | 42 K to 75.3 K (+79.36 %) |
Jun 06 2017 | NEO | NEOGENOMICS INC | ROSS STEVEN A | CIO | Buy | M | 3.93 | 37,500 | 147,375 | 42,000 | 4.5 K to 42 K (+833.33 %) |
May 30 2017 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Option Exercise | A | 0.00 | 8,667 | 0 | 8,667 | |
May 30 2017 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Option Exercise | A | 7.27 | 10,000 | 72,700 | 10,000 | |
May 30 2017 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Option Exercise | C | 0.00 | 5,072 | 0 | 0 | |
May 30 2017 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Option Exercise | C | 0.00 | 2,150 | 0 | 0 | |
May 30 2017 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Buy | M | 0.00 | 7,222 | 0 | 272,016 | 264.8 K to 272 K (+2.73 %) |
May 30 2017 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | A | 0.00 | 8,667 | 0 | 8,667 | |
May 30 2017 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | A | 7.27 | 10,000 | 72,700 | 10,000 | |
May 30 2017 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | C | 0.00 | 5,072 | 0 | 0 | |
May 30 2017 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | C | 0.00 | 2,150 | 0 | 0 | |
May 30 2017 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Buy | M | 0.00 | 7,222 | 0 | 21,782 | 14.6 K to 21.8 K (+49.60 %) |
May 30 2017 | NEO | NEOGENOMICS INC | CROWTHER BRUCE K | Director | Option Exercise | A | 0.00 | 8,667 | 0 | 8,667 | |
May 30 2017 | NEO | NEOGENOMICS INC | CROWTHER BRUCE K | Director | Option Exercise | A | 7.27 | 10,000 | 72,700 | 10,000 | |
May 30 2017 | NEO | NEOGENOMICS INC | CROWTHER BRUCE K | Director | Option Exercise | C | 0.00 | 5,072 | 0 | 0 | |
May 30 2017 | NEO | NEOGENOMICS INC | CROWTHER BRUCE K | Director | Option Exercise | C | 0.00 | 2,150 | 0 | 0 | |
May 30 2017 | NEO | NEOGENOMICS INC | CROWTHER BRUCE K | Director | Buy | M | 0.00 | 7,222 | 0 | 17,202 | 10 K to 17.2 K (+72.36 %) |
May 30 2017 | NEO | NEOGENOMICS INC | Robison William J | Director | Option Exercise | A | 0.00 | 8,667 | 0 | 8,667 | |
May 30 2017 | NEO | NEOGENOMICS INC | Robison William J | Director | Option Exercise | A | 7.27 | 10,000 | 72,700 | 10,000 | |
May 30 2017 | NEO | NEOGENOMICS INC | Robison William J | Director | Option Exercise | C | 0.00 | 5,072 | 0 | 0 | |
May 30 2017 | NEO | NEOGENOMICS INC | Robison William J | Director | Option Exercise | C | 0.00 | 2,150 | 0 | 0 | |
May 30 2017 | NEO | NEOGENOMICS INC | Robison William J | Director | Buy | M | 0.00 | 7,222 | 0 | 183,348 | 176.1 K to 183.3 K (+4.10 %) |
May 30 2017 | NEO | NEOGENOMICS INC | JONES STEVEN C | Executive VP of Fin ... | Option Exercise | A | 0.00 | 8,667 | 0 | 8,667 | |
May 30 2017 | NEO | NEOGENOMICS INC | JONES STEVEN C | Executive VP of Fin ... | Option Exercise | A | 7.27 | 10,000 | 72,700 | 10,000 | |
May 30 2017 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Option Exercise | A | 0.00 | 8,667 | 0 | 8,667 | |
May 30 2017 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Option Exercise | A | 7.27 | 10,000 | 72,700 | 10,000 | |
May 30 2017 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Option Exercise | C | 0.00 | 5,072 | 0 | 0 | |
May 30 2017 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Option Exercise | C | 0.00 | 2,150 | 0 | 0 | |
May 30 2017 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Buy | M | 0.00 | 7,222 | 0 | 128,309 | 121.1 K to 128.3 K (+5.96 %) |
May 30 2017 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Option Exercise | A | 0.00 | 8,667 | 0 | 8,667 | |
May 30 2017 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Option Exercise | A | 7.27 | 10,000 | 72,700 | 10,000 | |
May 30 2017 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Option Exercise | C | 0.00 | 5,072 | 0 | 0 | |
May 30 2017 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Option Exercise | C | 0.00 | 2,150 | 0 | 0 | |
May 30 2017 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Buy | M | 0.00 | 7,222 | 0 | 18,782 | 11.6 K to 18.8 K (+62.47 %) |
May 30 2017 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
May 30 2017 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | A | 0.00 | 197,042 | 0 | 197,042 | |
May 30 2017 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | Chief Financial Off ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
May 30 2017 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
May 30 2017 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Sell | S | 7.50 | 3,334 | 25,005 | 10,049 | 13.4 K to 10 K (-24.91 %) |
May 30 2017 | NEO | NEOGENOMICS INC | ALBITAR MAHER | Chief Medical Offic ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
May 02 2017 | NEO | NEOGENOMICS INC | BRODIE STEVEN G. | Vice President of O ... | Option Exercise | A | 7.52 | 50,000 | 376,000 | 50,000 | |
May 02 2017 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | A | 7.52 | 500,000 | 3,760,000 | 500,000 | |
May 02 2017 | NEO | NEOGENOMICS INC | ALBITAR MAHER | Chief Medical Offic ... | Option Exercise | A | 7.52 | 200,000 | 1,504,000 | 200,000 | |
May 02 2017 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | A | 7.52 | 200,000 | 1,504,000 | 200,000 | |
May 02 2017 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Option Exercise | A | 7.52 | 60,000 | 451,200 | 60,000 | |
May 02 2017 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | Chief Financial Off ... | Option Exercise | A | 7.52 | 200,000 | 1,504,000 | 200,000 | |
May 02 2017 | NEO | NEOGENOMICS INC | ROSS STEVEN A | CIO | Option Exercise | A | 7.52 | 65,000 | 488,800 | 65,000 | |
Mar 28 2017 | NEO | NEOGENOMICS INC | BRODIE STEVEN G. | President, Pharma S ... | Option Exercise | X | 3.76 | 10,000 | 37,600 | 0 | |
Mar 28 2017 | NEO | NEOGENOMICS INC | BRODIE STEVEN G. | President, Pharma S ... | Buy | X | 3.76 | 10,000 | 37,600 | 25,953 | 16 K to 26 K (+62.68 %) |
Mar 22 2017 | NEO | NEOGENOMICS INC | BRODIE STEVEN G. | President, Pharma S ... | Sell | S | 7.90 | 33,450 | 264,255 | 15,953 | 49.4 K to 16 K (-67.71 %) |
Mar 22 2017 | NEO | NEOGENOMICS INC | BRODIE STEVEN G. | President, Pharma S ... | Sell | S | 8.00 | 16,550 | 132,400 | 49,403 | 66 K to 49.4 K (-25.09 %) |
Mar 17 2017 | NEO | NEOGENOMICS INC | BRODIE STEVEN G. | President, Pharma S ... | Buy | S | 8.00 | 16,550 | 132,400 | 49,403 | 32.9 K to 49.4 K (+50.38 %) |
Feb 28 2017 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Option Exercise | X | 1.69 | 6,250 | 10,563 | 0 | |
Feb 28 2017 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Buy | M | 1.69 | 6,250 | 10,563 | 13,383 | 7.1 K to 13.4 K (+87.62 %) |
Feb 06 2017 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | X | 1.71 | 200,000 | 342,000 | 0 | |
Feb 06 2017 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Payment of Exercise | F | 8.14 | 42,015 | 342,002 | 1,832,985 | 1.9 M to 1.8 M (-2.24 %) |
Feb 06 2017 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | M | 1.71 | 200,000 | 342,000 | 1,875,000 | 1.7 M to 1.9 M (+11.94 %) |
Jan 04 2017 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Option Exercise | X | 4.78 | 3,333 | 15,932 | 22,222 | |
Jan 04 2017 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Buy | M | 4.78 | 3,333 | 15,932 | 121,087 | 117.8 K to 121.1 K (+2.83 %) |
Dec 27 2016 | NEO | NEOGENOMICS INC | JONES STEVEN C | Executive VP of Fin ... | Gift | G | 8.92 | 20,000 | 178,400 | 246,251 | 266.3 K to 246.3 K (-7.51 %) |
Dec 23 2016 | NEO | NEOGENOMICS INC | GENERAL ELECTRIC CO | 10% Owner | Option Exercise | J | 0.00 | 8,066,667 | 0 | 6,600,000 | |
Dec 07 2016 | NEO | NEOGENOMICS INC | BRODIE STEVEN G. | President, Pharma S ... | Option Exercise | X | 1.69 | 10,000 | 16,900 | 0 | |
Dec 07 2016 | NEO | NEOGENOMICS INC | BRODIE STEVEN G. | President, Pharma S ... | Buy | M | 1.69 | 10,000 | 16,900 | 65,953 | 56 K to 66 K (+17.87 %) |
Oct 11 2016 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Option Exercise | X | 1.10 | 3,334 | 3,667 | 0 | |
Oct 11 2016 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Buy | M | 1.10 | 3,334 | 3,667 | 7,133 | 3.8 K to 7.1 K (+87.76 %) |
Sep 27 2016 | NEO | NEOGENOMICS INC | ALBITAR MAHER | Chief Medical Offic ... | Sell | S | 8.40 | 2,800 | 23,520 | 60,692 | 63.5 K to 60.7 K (-4.41 %) |
Sep 22 2016 | NEO | NEOGENOMICS INC | ALBITAR MAHER | Chief Medical Offic ... | Sell | S | 8.20 | 105,300 | 863,460 | 0 | 105.3 K to 0 (-100.00 %) |
Sep 16 2016 | NEO | NEOGENOMICS INC | JONES STEVEN C | Executive VP of Fin ... | Option Exercise | S | 1.50 | 112,500 | 168,750 | 0 | |
Sep 16 2016 | NEO | NEOGENOMICS INC | JONES STEVEN C | Executive VP of Fin ... | Option Exercise | S | 1.50 | 112,500 | 168,750 | 0 | |
Sep 16 2016 | NEO | NEOGENOMICS INC | JONES STEVEN C | Executive VP of Fin ... | Option Exercise | S | 1.50 | 225,000 | 337,500 | 0 | |
Sep 13 2016 | NEO | NEOGENOMICS INC | ALBITAR MAHER | Chief Medical Offic ... | Sell | S | 8.21 | 51,000 | 418,710 | 105,300 | 156.3 K to 105.3 K (-32.63 %) |
Sep 13 2016 | NEO | NEOGENOMICS INC | ALBITAR MAHER | Chief Medical Offic ... | Sell | S | 8.31 | 9,075 | 75,413 | 156,300 | 165.4 K to 156.3 K (-5.49 %) |
Aug 23 2016 | NEO | NEOGENOMICS INC | ALBITAR MAHER | Chief Medical Offic ... | Option Exercise | X | 1.43 | 250,000 | 357,500 | 0 | |
Aug 23 2016 | NEO | NEOGENOMICS INC | ALBITAR MAHER | Chief Medical Offic ... | Option Exercise | X | 4.78 | 100,000 | 478,000 | 200,000 | |
Aug 23 2016 | NEO | NEOGENOMICS INC | ALBITAR MAHER | Chief Medical Offic ... | Option Exercise | X | 3.45 | 20,000 | 69,000 | 10,000 | |
Aug 23 2016 | NEO | NEOGENOMICS INC | ALBITAR MAHER | Chief Medical Offic ... | Option Exercise | X | 1.43 | 200,000 | 286,000 | 0 | |
Aug 23 2016 | NEO | NEOGENOMICS INC | ALBITAR MAHER | Chief Medical Offic ... | Payment of Exercise | F | 8.26 | 34,625 | 286,003 | 228,867 | 263.5 K to 228.9 K (-13.14 %) |
Aug 23 2016 | NEO | NEOGENOMICS INC | ALBITAR MAHER | Chief Medical Offic ... | Sell | S | 8.23 | 370,000 | 3,045,100 | 263,492 | 633.5 K to 263.5 K (-58.41 %) |
Aug 23 2016 | NEO | NEOGENOMICS INC | ALBITAR MAHER | Chief Medical Offic ... | Buy | M | 1.43 | 250,000 | 357,500 | 633,492 | 383.5 K to 633.5 K (+65.19 %) |
Aug 23 2016 | NEO | NEOGENOMICS INC | ALBITAR MAHER | Chief Medical Offic ... | Buy | M | 4.78 | 100,000 | 478,000 | 383,492 | 283.5 K to 383.5 K (+35.27 %) |
Aug 23 2016 | NEO | NEOGENOMICS INC | ALBITAR MAHER | Chief Medical Offic ... | Buy | M | 3.45 | 20,000 | 69,000 | 283,492 | 263.5 K to 283.5 K (+7.59 %) |
Aug 23 2016 | NEO | NEOGENOMICS INC | ALBITAR MAHER | Chief Medical Offic ... | Buy | M | 1.43 | 200,000 | 286,000 | 263,492 | 63.5 K to 263.5 K (+315.00 %) |
Aug 01 2016 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Option Exercise | A | 9.11 | 8,333 | 75,914 | 25,555 | |
Aug 01 2016 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Option Exercise | A | 0.00 | 5,072 | 0 | 7,222 | |
Jul 29 2016 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Option Exercise | A | 9.11 | 8,333 | 75,914 | 25,555 | |
Jul 29 2016 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Option Exercise | A | 0.00 | 5,072 | 0 | 7,222 | |
Jul 29 2016 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | A | 9.11 | 8,333 | 75,914 | 25,555 | |
Jul 29 2016 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | A | 0.00 | 5,072 | 0 | 7,222 | |
Jul 29 2016 | NEO | NEOGENOMICS INC | Robison William J | Director | Option Exercise | A | 9.11 | 8,333 | 75,914 | 22,222 | |
Jul 29 2016 | NEO | NEOGENOMICS INC | Robison William J | Director | Option Exercise | A | 0.00 | 5,072 | 0 | 7,222 | |
Jul 29 2016 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | A | 9.11 | 8,333 | 75,914 | 25,555 | |
Jul 29 2016 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | A | 0.00 | 5,072 | 0 | 7,222 | |
Jul 29 2016 | NEO | NEOGENOMICS INC | Robison William J | Director | Option Exercise | A | 9.11 | 8,333 | 75,914 | 22,222 | |
Jul 29 2016 | NEO | NEOGENOMICS INC | Robison William J | Director | Option Exercise | A | 0.00 | 5,072 | 0 | 7,222 | |
Jul 29 2016 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Option Exercise | A | 9.11 | 8,333 | 75,914 | 25,555 | |
Jul 29 2016 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Option Exercise | A | 0.00 | 5,072 | 0 | 7,222 | |
Jul 29 2016 | NEO | NEOGENOMICS INC | CROWTHER BRUCE K | Director | Option Exercise | A | 9.11 | 8,333 | 75,914 | 25,555 | |
Jul 29 2016 | NEO | NEOGENOMICS INC | CROWTHER BRUCE K | Director | Option Exercise | A | 0.00 | 5,072 | 0 | 7,222 | |
Jul 29 2016 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Option Exercise | A | 9.11 | 8,333 | 75,914 | 25,555 | |
Jul 29 2016 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Option Exercise | A | 0.00 | 5,072 | 0 | 7,222 | |
Jul 29 2016 | NEO | NEOGENOMICS INC | CROWTHER BRUCE K | Director | Option Exercise | A | 9.11 | 8,333 | 75,914 | 25,555 | |
Jul 29 2016 | NEO | NEOGENOMICS INC | CROWTHER BRUCE K | Director | Option Exercise | A | 0.00 | 5,072 | 0 | 7,222 | |
Jul 29 2016 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | A | 9.11 | 8,333 | 75,914 | 25,555 | |
Jul 29 2016 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | A | 0.00 | 5,072 | 0 | 7,222 | |
Jul 29 2016 | NEO | NEOGENOMICS INC | Robison William J | Director | Option Exercise | A | 9.11 | 8,333 | 75,914 | 22,222 | |
Jul 29 2016 | NEO | NEOGENOMICS INC | Robison William J | Director | Option Exercise | A | 0.00 | 5,072 | 0 | 7,222 | |
Jul 29 2016 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Option Exercise | A | 9.11 | 8,333 | 75,914 | 25,555 | |
Jul 29 2016 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Option Exercise | A | 0.00 | 5,072 | 0 | 7,222 | |
Jul 29 2016 | NEO | NEOGENOMICS INC | CROWTHER BRUCE K | Director | Option Exercise | A | 9.11 | 8,333 | 75,914 | 25,555 | |
Jul 29 2016 | NEO | NEOGENOMICS INC | CROWTHER BRUCE K | Director | Option Exercise | A | 0.00 | 5,072 | 0 | 7,222 | |
May 27 2016 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | X | 1.71 | 600,000 | 1,026,000 | 200,000 | |
May 27 2016 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Sell | S | 8.74 | 383,000 | 3,347,420 | 1,675,000 | 2.1 M to 1.7 M (-18.61 %) |
May 27 2016 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Sell | S | 8.69 | 98,387 | 854,983 | 2,058,000 | 2.2 M to 2.1 M (-4.56 %) |
May 27 2016 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Payment of Exercise | F | 8.65 | 118,613 | 1,026,002 | 2,156,387 | 2.3 M to 2.2 M (-5.21 %) |
May 27 2016 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | M | 1.71 | 600,000 | 1,026,000 | 2,275,000 | 1.7 M to 2.3 M (+35.82 %) |
May 20 2016 | NEO | NEOGENOMICS INC | ROSS STEVEN A | CIO | Option Exercise | X | 4.78 | 18,000 | 86,040 | 67,000 | |
May 20 2016 | NEO | NEOGENOMICS INC | ROSS STEVEN A | CIO | Sell | S | 8.50 | 18,000 | 153,000 | 4,500 | 22.5 K to 4.5 K (-80.00 %) |
May 20 2016 | NEO | NEOGENOMICS INC | ROSS STEVEN A | CIO | Buy | M | 4.78 | 18,000 | 86,040 | 22,500 | 4.5 K to 22.5 K (+400.00 %) |
May 10 2016 | NEO | NEOGENOMICS INC | Robison William J | Director | Option Exercise | X | 4.78 | 3,333 | 15,932 | 6,667 | |
May 10 2016 | NEO | NEOGENOMICS INC | Robison William J | Director | Buy | M | 4.78 | 3,333 | 15,932 | 177,196 | 173.9 K to 177.2 K (+1.92 %) |
May 10 2016 | NEO | NEOGENOMICS INC | CROWTHER BRUCE K | Director | Grant | A | 7.15 | 2,150 | 15,373 | 12,130 | 10 K to 12.1 K (+21.54 %) |
May 10 2016 | NEO | NEOGENOMICS INC | ROSS STEVEN A | CIO | Option Exercise | X | 4.78 | 15,000 | 71,700 | 85,000 | |
May 10 2016 | NEO | NEOGENOMICS INC | ROSS STEVEN A | CIO | Sell | S | 8.22 | 15,000 | 123,300 | 4,500 | 19.5 K to 4.5 K (-76.92 %) |
May 10 2016 | NEO | NEOGENOMICS INC | ROSS STEVEN A | CIO | Buy | M | 4.78 | 15,000 | 71,700 | 19,500 | 4.5 K to 19.5 K (+333.33 %) |
May 06 2016 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Grant | A | 7.15 | 2,150 | 15,373 | 266,944 | 264.8 K to 266.9 K (+0.81 %) |
May 04 2016 | NEO | NEOGENOMICS INC | Robison William J | Director | Grant | A | 7.15 | 2,150 | 15,373 | 173,863 | 171.7 K to 173.9 K (+1.25 %) |